Breaking News
Investing Pro 0
⏰ React to the Market Faster with Custom, Real-Time News Get Started
Close

Altimmune Inc (3G0)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.897 -0.015    -0.37%
09:44:00 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US02155H2004 
S/N:  A2N5Z6
  • Volume: 50
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 3.819 - 3.968
Altimmune 3.897 -0.015 -0.37%

3G0 Financial Summary

 
A brief financial summary of Altimmune Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Altimmune, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported negative sales was USD 0.11 million compared to sales of USD 3.28 million a year ago. Net loss was USD 21.66 million compared to USD 23.89 million a year ago. Basic loss per share from continuing operations was USD 0.43 compared to USD 0.57 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

3G0 Income Statement

Gross margin TTM 103,705.88%
Operating margin TTM 128,902.94%
Net Profit margin TTM 124,577.94%
Return on Investment TTM -38.95%
 Total Revenue  Net Income
Period Ending: Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Total Revenue -0.11 0.002 0.008 0.032
Gross Profit -19.29 -20.26 -15.98 -16.85
Operating Income -23.09 -24.75 -20.4 -21.28
Net Income -21.66 -23.52 -20.11 -19.43

3G0 Balance Sheet

Quick Ratio MRQ 10.85
Current Ratio MRQ 11.31
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 0.61%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Total Assets 206.93 225.28 209.91 205.66
Total Liabilities 20.25 15.37 20.79
Total Equity 205.03 194.54 184.87

3G0 Cash Flow Statement

Cash Flow/Share TTM -1.27
Revenue/Share TTM 0
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -15.05 -16.7 -13.53
Cash From Investing Activities -25.4 -48.97 -0.009
Cash From Financing Activities -0.043 32.06 21.58 3.18
Net Change in Cash -16.37 -8.39 -44.09 -10.35
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALT Comments

Write your thoughts about Altimmune Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Giuseppe Giannachi
Giuseppe Giannachi Mar 21, 2023 2:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Clinical trials and results seem very positive but the stock is tanking. Help me... cheers.
Giuseppe Giannachi
Giuseppe Giannachi Sep 14, 2022 12:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone around?
Jack Nicholson
Jack Nicholson Aug 12, 2021 12:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I've seen this one before, it looks like a come back but when I buy it, it goes down to a dollar. I'm not buying it though so it will probably do great ;o)
Ken Burian
Ken Burian Aug 12, 2021 12:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol. i would recommend you buy the stock and put in a stop loss to limit the potential damage for a speculative stock like this. i believed in this comeback early, so i bought in a month ago at 9. its been a nice run. i am now expecting a little pause, so i may sell some short term calls to take in a little profit.
Dirar Haddadin
Dirar Haddadin Aug 12, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is the sxpectations ?
Zoran Labus
Zoran Labus Mar 26, 2021 7:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
alan abbas
alan abbas Feb 18, 2021 10:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
check out RIGL
Johnny Walker
Johnny Walker Feb 17, 2021 8:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
28?
Lucas Ang
Lucas Ang Feb 12, 2021 4:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great stock
Mohmoh lolkk
Mohmoh lolkk Dec 18, 2020 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
20.000plz
Mohmoh lolkk
Mohmoh lolkk Dec 18, 2020 10:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
20.000plz
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email